Chemoinformaics analysis of 7-HYDROXY-6-METHOXY-2-METHYL-3,4-DIHYDROISOQUINOLIN-1-ONE
Molecular Weight | 207.229 | nRot | 1 |
Heavy Atom Molecular Weight | 194.125 | nRig | 7 |
Exact Molecular Weight | 207.09 | nRing | 2 |
Solubility: LogS | -1.691 | nHRing | 1 |
Solubility: LogP | 2.917 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 30.5443 |
nHD | 1 | BPOL | 17.3557 |
QED | 0.663 |
Synth | 3.208 |
Natural Product Likeliness | 1.199 |
NR-PPAR-gamma | 0.935 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.006 |
HIA | 0.011 |
CACO-2 | -5.588 |
MDCK | 0.0000211 |
BBB | 0.091 |
PPB | 0.977873 |
VDSS | 0.422 |
FU | 0.0429729 |
CYP1A2-inh | 0.012 |
CYP1A2-sub | 0.09 |
CYP2c19-inh | 0.015 |
CYP2c19-sub | 0.052 |
CYP2c9-inh | 0.023 |
CYP2c9-sub | 0.911 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.146 |
CYP3a4-inh | 0.009 |
CYP3a4-sub | 0.029 |
CL | 7.696 |
T12 | 0.945 |
hERG | 0.001 |
Ames | 0.009 |
ROA | 0.104 |
SkinSen | 0.524 |
Carcinogencity | 0.739 |
EI | 0.136 |
Respiratory | 0.545 |
NR-Aromatase | 0.069 |
Antiviral | No |
Prediction | 0.715777 |